moneymaker_BX schreef op 17 oktober 2017 15:51:
ryze intravenous injection, Shire
500 unit, preservative-free vial (NDC 42227-0081-05)
Reason for the Shortage
CSL Behring has Berinert on shortage due to increased demand.
Shire has resumed manufacturing of Cinryze and certain lots are available.
The subcutaneous dosage form of C1-esterase inhibitor (human) is unaffected by this shortage.
Available Products
There is insufficient supply for usual ordering
Estimated Resupply Dates
CSL Behring is shipping limited supplies of Berinert to specialty distributers.
Shire has certain lots of Cinryze available.